Navigation Links
Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment
Date:6/9/2009

Customizable Survival Kit Offers One Stop for Market-Specific Managed Care Enrollment Data and Insights into Local Healthcare Market Drivers and Health Plan Trends

NASHVILLE, Tenn., June 9 /PRNewswire/ --HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that commercial pharmacy enrollment is experiencing greater shifts in membership at the state level than commercial medical benefit enrollment. According to new data from HealthLeaders-InterStudy, Florida is one market in which commercial medical and pharmacy benefit enrollment is moving in different directions. Between January 2008 and January 2009, commercial medical enrollment in Florida grew by nearly three percent, while commercial pharmacy enrollment decreased by 10 percent.

Enrollment details, along with insights into local healthcare market drivers and health plan trends can be found in a customizable Survival Kit from HealthLeaders-InterStudy. The Kit, which can be tailored for Florida or any U.S. market, arms pharmaceutical sales teams with local-level managed care market intelligence. To meet sales force needs, District, Area, Territory and Region Survival Kits are available.

Each Survival Kit can be customized to provide the most relevant quantitative and qualitative insights that will enable teams to assess priorities and understand market drivers, influencers and opportunities. Accurate and comprehensive enrollment information allows teams to evaluate how medical and pharmacy lives are covered in a particular district to improve strategic planning and resource allocation.

"Gathering market intelligence can be time-consuming and expensive, and without the validation of a third-party expert, companies often do not get the complete picture," said Jed Maley, vice president, business development with HealthLeaders-InterStudy. "Our survival kits combine our data and analysis products into a geography-specific kit, allowing sales teams to quickly gain knowledge about local and regional key players, and better understand the environment in which they operate to uncover new opportunities or better leverage existing ones."

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

###

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
2. China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
3. ProSolv Version 4.0.2 Makes Commercial Debut at ASE
4. moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
5. Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
6. BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
7. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
8. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
9. Althea Technologies Completes New State-of-the-Art, Commercial-Scale, Biologics and Injectables Manufacturing Facility
10. Building on Growth, Virtify Adds to Executive Team and Expands Commercial Operations
11. InfuSystem Appoints Bryan Russo as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... For over twenty-four years, Doctors on Liens ... personal injury victims find high quality medical care. When the company started in 1997, ... Fast forward to present day and the now ten-page directory features a vast array of ...
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to host ... other developmental disabilities. The group, which is being launched with the help of Robbie ... share stories and advice, seek help, and continue their education on how to best ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s ... ostomy patients, standing as living proof that attitude and determination can combine into ... issues that spike around the holidays. This campaign will offer patients a new-found ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and ... storing, shipping and disposal. The new version is a faster and a more ...
(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that measures ... on the market can deliver all that rejiva can. , “Rejiva promotes relaxation and ... than the usual heart rate and steps taken”, adds Evens Augustin, CEO of Rijuven. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), ... Specialties, Inc. ("PSI").  The combination of Texas ... -based PSI bring together both company,s clinical expertise and ... payers an industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... MARLBOROUGH, Mass. , Dec. 2, 2016 ... announced a definitive agreement to acquire certain manufacturing assets ... NVCN ) (TSX: NVC) advanced biological tissue business, as ... a total of $75 million in cash. The Neovasc ... heart valves, including the Boston Scientific Lotus™ Valve System. ...
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
Breaking Medicine Technology: